|Details: 20 kta United States-based plant | Q2 2023 | 109 pages | See Versions From $1,199 USD|
This report presents an up-to-date, detailed cost analysis of Laurolactam production from cyclododecane. The process examined is similar to the one owned by Evonik. The process examined involves the following steps: cyclododecane oxidation to cyclododecanol; cyclododecanol dehydrogenation to cyclododecanone; cyclododecanone oximation with hydroxylamine; and, finally, a Beckmann rearrangement of the oxime to produce laurolactam.
This report, Laurolactam E11A, is a best-in-class examination of Laurolactam production, providing an in-depth, comprehensive techno-economic analysis of the production technology examined, including:
- Process Description: raw materials and utilities consumption, products generation, labor requirements, list of equipment, characterization of site infrastructure, process flow diagram (PFD).
- Capital Cost Analysis: costs of plant construction, working capital, owners' costs, commissioning, start-up and contingency.
- Operating Cost Analysis: variable costs, fixed costs (salary, benefits & maintenance) and corporate overhead costs.
- And much more . . .